Literature DB >> 26362052

Left ventricular outflow tract obstruction masked by severe aortic stenosis.

Shinya Fukui1, Masataka Mitsuno1, Mitsuhiro Yamamura1, Hiroe Tanaka1, Masaaki Ryomoto1, Tetsuya Kajiyama1, Ayaka Sato1, Yuji Miyamoto2.   

Abstract

An 81-year-old woman developed severe hemolytic anemia after aortic valve replacement. The anemia was not caused by paravalvular leakage, as in most cases. Instead, it occurred secondary to left ventricular outflow tract obstruction that had not been seen preoperatively and was induced by afterload reduction following aortic valve replacement. The hemolytic anemia was drug-refractory and finally treated with dual-chamber pacing, as for hypertrophic cardiomyopathy.

Entities:  

Keywords:  Aortic valve replacement; Hypertrophic obstructive cardiomyopathy; Mitral systolic anterior motion; Pacemaker

Mesh：

Year:  2015        PMID： 26362052     DOI： 10.1007/s11748-015-0586-z

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  9 in total

1.  Severe hemolytic anemia in hypertrophic cardiomyopathy.

Authors:  S Peláez-Dominguez; L Pérez-Benito; J Sanz Moreno; I García Calvo; J Ruiz Morales; A Palomo Bravo
Journal:  Am Heart J       Date:  1992-10       Impact factor: 4.749

2.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

Review 3.  Subvalvular left ventricular outflow obstruction for patients undergoing aortic valve replacement for aortic stenosis: echocardiographic recognition and identification of patients at risk.

Authors:  David S Bach
Journal:  J Am Soc Echocardiogr       Date:  2005-11       Impact factor: 5.251

4.  Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).

Authors:  B J Maron; R A Nishimura; W J McKenna; H Rakowski; M E Josephson; R S Kieval
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

5.  Usefulness of tissue Doppler imaging for demonstrating altered septal contraction sequence during dual-chamber pacing in obstructive hypertrophic cardiomyopathy.

Authors:  Takahide Ito; Michihiro Suwa; Yasuhiko Sakai; Tomomi Hozumi; Yasushi Kitaura
Journal:  Am J Cardiol       Date:  2005-10-21       Impact factor: 2.778

6.  Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy.

Authors:  Toru Kubo; Hiroaki Kitaoka; Yasunobu Terauchi; Shinjiro Tamura; Makoto Okawa; Naohito Yamasaki; Toshikazu Yabe; Yoshinori L Doi
Journal:  J Cardiol       Date:  2009-05-09       Impact factor: 3.159

7.  Abnormal systolic intraventricular flow velocities after valve replacement for aortic stenosis. Mechanisms, predictive factors, and prognostic significance.

Authors:  J Bartunek; S U Sys; A C Rodrigues; E van Schuerbeeck; L Mortier; B de Bruyne
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

8.  Abnormal left ventricular intracavitary flow acceleration in patients undergoing aortic valve replacement for aortic stenosis. A marker for high postoperative morbidity and mortality.

Authors:  G Aurigemma; S Battista; D Orsinelli; A Sweeney; L Pape; H Cuénoud
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

9.  Concomitant septal myectomy at the time of aortic valve replacement for severe aortic stenosis.

Authors:  Nihan Kayalar; Hartzell V Schaff; Richard C Daly; Joseph A Dearani; Soon J Park
Journal:  Ann Thorac Surg       Date:  2010-02       Impact factor: 4.330
  9 in total
  1 in total

1.  Evaluation and Management of Concomitant Hypertrophic Obstructive Cardiomyopathy and Valvular Aortic Stenosis.

Authors:  John Shenouda; David Silber; Mythri Subramaniam; Basil Alkhatib; Richard K Schwartz; John A Goncalves; Srihari S Naidu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.